Point-of-care diagnostics to combat antibiotic resistance.☆
|AFFILIATION:||ID Genomics, Inc., Seattle, Washington, United States|
Track: Medical & Biotech
Area: Infectious Disease
Tech Readiness: TRL 6
Tech Brief: We are developing diagnostic tools that guide antibiotic prescriptions in the clinic. These tools offer precise prescriptions and limit drug resistance. Further, our tools enable antibiotic resistance surveillance, allowing clinicians to pinpoint resistance outbreaks and improving antibiotic stewardship in the community.
Value Proposition: With the emergence of multidrug resistant organisms (MDRO), the Military Health System faces a paradigm where once again, infectious diseases claim more lives than battle-related injuries. The current approach to treating combat injuries is to ‘fail until you succeed’. If the infection fails standard treatment, Soldiers are treated with increasingly aggressive drugs with the hope that the infection will eventually resolve. This process can result in persistent infections, limb loss, extensive hospitalization, sepsis, or death. IDG’s diagnostic tools guide treatment choices correctly the first time by matching the infecting bug with the correct drug. Our prototype diagnostic guides the correct antibiotic choices for Gram-negative Escherichia coli. We are developing diagnostics for other MDRO’s relevant to combat injured personnel, including Acenitobacter baumanii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. In addition to CLoNeT kits for each of these organisms, BactNet can pinpoint MDRO outbreaks in forward deployed facilities. This real-time surveillance can detect new superbugs early and contain their inadvertent transmission to receiving military medical centers or civilian hospitals. IDG’s tools offer the unique ability to respond to patient needs while simultaneously detecting global superbug outbreaks.
Org Type: Mid-stage Startup (A or B)
Booth Number: W313